Jobbörse
Finde Jobs in deiner Nähe – ob vor Ort, hybrid oder remote.- Ähnliche Jobs zu: Facilities Manager - Cannock
Facilities Manager - Oxford
ImmunocoreBarton
Facilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCumnorFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreMarsh BaldonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEynshamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreStanton HarcourtFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBladonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCulhamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreClifton HampdenFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreLittle MiltonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreWoodstockFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreNewingtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreDorchesterFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreKingston BagpuizeFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreNorth LeighFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreWarboroughFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreYelfordFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBrillFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreWest HanneyFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBrightwell BaldwinFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocorePuseyFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCuxhamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreThameFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreGroveFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEwelmeFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreUpper HeyfordFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
